BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28735755)

  • 1. Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT.
    Kirkham AA; Shave RE; Bland KA; Bovard JM; Eves ND; Gelmon KA; McKenzie DC; Virani SA; Stöhr EJ; Warburton DER; Campbell KL
    Int J Cardiol; 2017 Oct; 245():263-270. PubMed ID: 28735755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
    Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
    Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure.
    Pastormerlo LE; Agazio A; Benelli E; Gabutti A; Poletti R; Prontera C; Clerico A; Emdin M; Passino C
    Am J Cardiol; 2015 Aug; 116(4):567-72. PubMed ID: 26089013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT.
    Kirkham AA; Eves ND; Shave RE; Bland KA; Bovard J; Gelmon KA; Virani SA; McKenzie DC; Stöhr EJ; Waburton DER; Campbell KL
    Breast Cancer Res Treat; 2018 Feb; 167(3):719-729. PubMed ID: 29110150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation to NT-ProBNP and remodeling after cardiac surgery.
    Boer BP; Vieira ML; Sampaio RO; Abensur H; Oliveira AG; Fernandes JR; Grinberg M
    Arq Bras Cardiol; 2013 May; 100(5):469-75. PubMed ID: 23579620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of NT-proBNP and various echocardiographic methods in the determination of doxorubicin induced subclinical late cardiotoxicity.
    Yildirim A; Tunaoglu FS; Kambur K; Pinarli FG
    Kardiol Pol; 2013; 71(1):40-6. PubMed ID: 23348532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy with tamoxifen reduces plasma levels of NT-B-type natriuretic peptide but does not change ventricular ejection fraction after chemotherapy in women with breast cancer.
    Silva FB; Romero WG; Carvalho AL; Borgo MV; Amorim MH; Gouvea SA; Abreu GR
    Braz J Med Biol Res; 2015 Feb; 48(2):154-60. PubMed ID: 25424369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.
    Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W
    Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure.
    Rengo G; Pagano G; Parisi V; Femminella GD; de Lucia C; Liccardo D; Cannavo A; Zincarelli C; Komici K; Paolillo S; Fusco F; Koch WJ; Perrone Filardi P; Ferrara N; Leosco D
    Int J Cardiol; 2014 Feb; 171(3):384-9. PubMed ID: 24388546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.
    Berent R; von Duvillard SP; Crouse SF; Auer J; Green JS; Sinzinger H; Schmid P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):603-8. PubMed ID: 19494782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM; Beckers P; Vaes J; Martin M; Van Hoof V; De Maeyer C; Possemiers N; Wuyts FL; Vrints CJ
    Eur Heart J; 2004 Oct; 25(20):1797-805. PubMed ID: 15474694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
    Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
    Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise dependence of N-terminal pro-brain natriuretic peptide in patients with precapillary pulmonary hypertension.
    Grachtrup S; Brügel M; Pankau H; Halank M; Wirtz H; Seyfarth HJ
    Respiration; 2012; 84(6):454-60. PubMed ID: 22327025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.